• Getting Started

   

     

  Getting started with PathoGenius^®

  READ MORE

• Wound Care

   

     

  PathoGenius^® offers DNA guided, personalized medicine for wound care.

  READ MORE

• ENT and Respiratory Tract

   

   

  PathoGenius^® offers specifically designed Rapid screening for ENT applications and comprehensive bacterial and fungal diagnostics.

  READ MORE ​

• Respiratory Viral Panel

   

   

  PathoGenius^® extends rapid screen molecular diagnostics for ENT and respiratory viruses.

  READ MORE

• Bacterial Vaginosis/Yeast Infections

   

   

  PathoGenius^® offers specifically designed Rapid screening for BV as well as comprehensive bacterial and fungal diagnostics persistent infections.

  READ MORE

 

Respiratory Viral Panel

 

Researchers are estimating that about 200 million people are infected by viral community-acquired pneumonia every year. Approximately 100 million of these cases are children, and 100 million are adults. Molecular diagnostic tests have shed light on the role of viruses in pneumonia, and current research indicates that the incidence of viral pneumonia is severely underestimated. In children, dual viral infections are common, and a third of children show evidence of having simultaneous viral and bacterial infections. In adults, viruses are alleged to be the cause of a third of the reported cases of community-acquired pneumonia; in particular influenza viruses, rhinoviruses, and coronaviruses. However, bacteria continue to have a predominant role in adults with pneumonia. Currently, physicians rely on the presence of viral epidemics in the community, a patient's age, speed of illness onset, symptoms, biomarkers, radiographic changes, and response to treatment in order to differentiate viral from bacterial pneumonia. Without molecular diagnostics, physicians have no clear reason to treat patients with obvious viral community-acquired pneumonia with antibiotics as well. By utilizing both the bacterial and viral molecular diagnostic panels offered by PathoGenius^®, physicians can understand the cause and pathogenesis of community-acquired pneumonia and other respiratory infections, and select the most targeted, effective approach possible to speed patient healing.

 

Targeted Respiratory Viruses

•   Adenovirus B/E

•   Adenovirus C

•   Human Metapneumovirus (HMPV)

•   Human Rhinovirus (HRV)

•   Influenza A

•   Influenza A 2009 H1N1

•   Influenza A H1

•   Influenza A H3

•   Influenza B

•   Parainfluenza Virus (PIV) 1

•   Parainfluenza Virus (PIV) 2

•   Parainfluenza Virus (PIV) 3

•   Respiratory Synclytial Virus (RSV) A

•   Respiratory Synclytial Virus (RSV) B

 

Respiratory Viral Panel Sensitivity

The viral panel offered by PathoGenius^® is the most sensitive respiratory viral panel test available based on an independent study of 300 specimens comparing molecular respiratory virus panels (Popowitch, JClinMicroBiol 2013). The overall sensitivity and specificity, respectively, and 95% confidence interval (confidence interval in parentheses) is 98.3% (95.5, 99.5) and 99.2% (95.4, 100).

 

Clinical Evidence for Molecular Diagnostics